Kera Capital Partners Inc. Makes New $219,000 Investment in Colgate-Palmolive (NYSE:CL)

Kera Capital Partners Inc. purchased a new position in shares of Colgate-Palmolive (NYSE:CLFree Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,409 shares of the company’s stock, valued at approximately $219,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. XTX Topco Ltd bought a new position in Colgate-Palmolive during the 2nd quarter worth $423,000. Ieq Capital LLC lifted its stake in shares of Colgate-Palmolive by 22.6% in the second quarter. Ieq Capital LLC now owns 38,617 shares of the company’s stock worth $3,747,000 after acquiring an additional 7,130 shares during the period. AE Wealth Management LLC boosted its holdings in Colgate-Palmolive by 70.9% in the second quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock valued at $2,194,000 after acquiring an additional 9,382 shares during the last quarter. Sei Investments Co. increased its position in Colgate-Palmolive by 1.8% during the 2nd quarter. Sei Investments Co. now owns 609,139 shares of the company’s stock valued at $59,111,000 after purchasing an additional 10,500 shares during the period. Finally, Summit Trail Advisors LLC raised its holdings in Colgate-Palmolive by 2.6% during the 2nd quarter. Summit Trail Advisors LLC now owns 5,490 shares of the company’s stock worth $533,000 after purchasing an additional 141 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of analyst reports. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a research note on Friday. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. Piper Sandler dropped their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, UBS Group dropped their price target on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $101.11.

Read Our Latest Report on CL

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $88.79 on Monday. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The business has a 50 day moving average price of $92.20 and a 200-day moving average price of $97.75. The company has a market cap of $72.55 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.